Cargando…
Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group
BACKGROUND: Myocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI an...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research and Publications Office of Jimma University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036464/ https://www.ncbi.nlm.nih.gov/pubmed/32116427 http://dx.doi.org/10.4314/ejhs.v30i1.2 |
_version_ | 1783500224283541504 |
---|---|
author | Shamshirian, Amir Alizadeh-Navaei, Reza Abedi, Samira Jafarpour, Hamed Fazli, Hanieh Hosseini, Samira Hessami, Amirhossein Karimifar, Keyvan Yosefi, Sedighe Zahedi, Mohammad Motamen, Sepideh Ghorbanpour, Atiyeh Zarandi, Bahman Esfahani, Aliakbar Rostamian-Moghaddam, Yeganeh Mehdipour, Shirin Heydari, Keyvan Aghajanian, Sedigheh Mehdi, Somayeh Pour Azad, Alireza Azizi, Soheil |
author_facet | Shamshirian, Amir Alizadeh-Navaei, Reza Abedi, Samira Jafarpour, Hamed Fazli, Hanieh Hosseini, Samira Hessami, Amirhossein Karimifar, Keyvan Yosefi, Sedighe Zahedi, Mohammad Motamen, Sepideh Ghorbanpour, Atiyeh Zarandi, Bahman Esfahani, Aliakbar Rostamian-Moghaddam, Yeganeh Mehdipour, Shirin Heydari, Keyvan Aghajanian, Sedigheh Mehdi, Somayeh Pour Azad, Alireza Azizi, Soheil |
author_sort | Shamshirian, Amir |
collection | PubMed |
description | BACKGROUND: Myocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI and blood examination variables. METHODS: This study was conducted in Mazandaran Heart Center as a hospital-based case-control Comprising 894 participants including 465 cases and 429 controls, individually matched by sex and age. Considered blood markers were analyzed using routine laboratory methods and equipment. RESULTS: Of all participants, 64.3% of the cases and 51.0% of the controls were males with a mean age of 61.2 (±13.8) in cases and 62.4 (±14.) in controls. We could not find any differences between cases and controls for total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and alkaline-phosphatase (ALP) (P>0.05). However, levels of creatine-kinase-muscle/brain (CK-MB) (P<0.0001), fasting-blood-sugar (FBS) (P<0.0001), aspartate-aminotransferase (AST) (P<0.0001), alanine-transferase (ALT) (P<0.0001) and erythrocyte sedimentation rate (ESR) (P=0.001) were significantly higher in cases compared to the controls (P<0.05). Multivariable analyses revealed that the risk of MI was associated with high levels of AST (adjusted OR=24.3, 95%CI=3.5±165.6, P=0.001) and LDL (adjusted OR=7.4, 95%CI=1.0±51.8, P=0.001). CONCLUSION: Our investigation indicated that the levels of CK-MB, FBS, AST, ALT and ESR were significantly higher in patients with MI. Besides, our findings showed that the risk of MI in cases with high levels of AST and LDL was about 24 and 7 times more than the control group respectively. |
format | Online Article Text |
id | pubmed-7036464 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Research and Publications Office of Jimma University |
record_format | MEDLINE/PubMed |
spelling | pubmed-70364642020-02-28 Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group Shamshirian, Amir Alizadeh-Navaei, Reza Abedi, Samira Jafarpour, Hamed Fazli, Hanieh Hosseini, Samira Hessami, Amirhossein Karimifar, Keyvan Yosefi, Sedighe Zahedi, Mohammad Motamen, Sepideh Ghorbanpour, Atiyeh Zarandi, Bahman Esfahani, Aliakbar Rostamian-Moghaddam, Yeganeh Mehdipour, Shirin Heydari, Keyvan Aghajanian, Sedigheh Mehdi, Somayeh Pour Azad, Alireza Azizi, Soheil Ethiop J Health Sci Original Article BACKGROUND: Myocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI and blood examination variables. METHODS: This study was conducted in Mazandaran Heart Center as a hospital-based case-control Comprising 894 participants including 465 cases and 429 controls, individually matched by sex and age. Considered blood markers were analyzed using routine laboratory methods and equipment. RESULTS: Of all participants, 64.3% of the cases and 51.0% of the controls were males with a mean age of 61.2 (±13.8) in cases and 62.4 (±14.) in controls. We could not find any differences between cases and controls for total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and alkaline-phosphatase (ALP) (P>0.05). However, levels of creatine-kinase-muscle/brain (CK-MB) (P<0.0001), fasting-blood-sugar (FBS) (P<0.0001), aspartate-aminotransferase (AST) (P<0.0001), alanine-transferase (ALT) (P<0.0001) and erythrocyte sedimentation rate (ESR) (P=0.001) were significantly higher in cases compared to the controls (P<0.05). Multivariable analyses revealed that the risk of MI was associated with high levels of AST (adjusted OR=24.3, 95%CI=3.5±165.6, P=0.001) and LDL (adjusted OR=7.4, 95%CI=1.0±51.8, P=0.001). CONCLUSION: Our investigation indicated that the levels of CK-MB, FBS, AST, ALT and ESR were significantly higher in patients with MI. Besides, our findings showed that the risk of MI in cases with high levels of AST and LDL was about 24 and 7 times more than the control group respectively. Research and Publications Office of Jimma University 2020-01 /pmc/articles/PMC7036464/ /pubmed/32116427 http://dx.doi.org/10.4314/ejhs.v30i1.2 Text en © 2020 Shamshirian A, et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Original Article Shamshirian, Amir Alizadeh-Navaei, Reza Abedi, Samira Jafarpour, Hamed Fazli, Hanieh Hosseini, Samira Hessami, Amirhossein Karimifar, Keyvan Yosefi, Sedighe Zahedi, Mohammad Motamen, Sepideh Ghorbanpour, Atiyeh Zarandi, Bahman Esfahani, Aliakbar Rostamian-Moghaddam, Yeganeh Mehdipour, Shirin Heydari, Keyvan Aghajanian, Sedigheh Mehdi, Somayeh Pour Azad, Alireza Azizi, Soheil Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group |
title | Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group |
title_full | Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group |
title_fullStr | Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group |
title_full_unstemmed | Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group |
title_short | Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group |
title_sort | levels of blood biomarkers among patients with myocardial infarction in comparison to control group |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7036464/ https://www.ncbi.nlm.nih.gov/pubmed/32116427 http://dx.doi.org/10.4314/ejhs.v30i1.2 |
work_keys_str_mv | AT shamshirianamir levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT alizadehnavaeireza levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT abedisamira levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT jafarpourhamed levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT fazlihanieh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT hosseinisamira levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT hessamiamirhossein levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT karimifarkeyvan levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT yosefisedighe levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT zahedimohammad levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT motamensepideh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT ghorbanpouratiyeh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT zarandibahman levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT esfahanialiakbar levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT rostamianmoghaddamyeganeh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT mehdipourshirin levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT heydarikeyvan levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT aghajaniansedigheh levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT mehdisomayehpour levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT azadalireza levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup AT azizisoheil levelsofbloodbiomarkersamongpatientswithmyocardialinfarctionincomparisontocontrolgroup |